ASTELLAS PHARMA INC Stock Dividends Overview

ALPMY pays dividends biannually. Last paid amount was $0.198 at Mar 27, 2024. As of today, dividend yield (TTM) is 3.28%.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.
AI Analysis of ALPMY
Powered by GPT-4
New!
Dividend Analysis

Key Stats

Dividend Yield (TTM) 3.28%
Frequency Biannually
1Y Growth 18.03%
Payout Ratio 0
Amount Per Share $0.198
ASTELLAS PHARMA INC has not yet announced its next dividend date. Last payment date was: Mar 27, 2024.

ALPMY Dividend Payout History

To ensure a understanding of ALPMY's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 27, 2024 Mar 27, 2024 Mar 27, 2024 $0.198 1.81%
2 Sep 28, 2023 Sep 28, 2023 Dec 18, 2023 $0.168 1.47%
3 Mar 30, 2023 Mar 30, 2023 Jun 16, 2023 $0.153 0.95%
4 Sep 29, 2022 Sep 29, 2022 Dec 01, 2022 $0.156 1.00%
5 Sep 28, 2021 Sep 28, 2021 Sep 28, 2021 $0.220 1.32%
6 Mar 29, 2021 Mar 29, 2021 Mar 29, 2021 $0.192 1.23%

Dividend Sustainability

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Sustainability score

Average (86.24%)

Growth potential

Increase likely (50.00%)

ALPMY Dividend Calculator

Dividend Calculator is designed to forecast the potential returns from ALPMY dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in ALPMY stock here.

Comparing ALPMY to Sector and Country

ALPMY pays a solid dividend yield of 3.28%, which is higher than the average of the bottom 25% of dividend payers in the US market (0.373%). ALPMY’s dividend yield is lower than the average of the top 25% of dividend payers in the Healthcare sector in the US market (7.44%), which means that there are more attractive dividend stocks to consider.

FAQ

What factors can affect the amount of ALPMY's dividend payments?
The amount of ALPMY's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in ALPMY sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from ALPMY stock be automatically reinvested?
If ALPMY offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy ALPMY stock.

How often does ALPMY pay dividend?
ASTELLAS PHARMA INC (ALPMY) pays dividends biannually. The most recent payout was on Mar 27, 2024.

How much does ALPMY pays per share?
The last recorder (Mar 27, 2024) dividend per share was $0.198.

What is ALPMY dividend growth rate?
Over the last year, ASTELLAS PHARMA INC has witnessed growth rate of 18.03% . Looking back over the past 3 years, this growth rate has been -3.52%. Furthermore, examining the past 5 years, ASTELLAS PHARMA INC has maintained an average Dividends Per Share Growth Rate of 0.625%.
Click to get the best stock tips daily for free!

About ASTELLAS PHARMA INC

ASTELLAS PHARMA INC Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a ... ALPMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT